First Page | Document Content | |
---|---|---|
Date: 2011-10-27 08:41:37Pharmaceutical industry Food and Drug Administration Clinical research Pharmaceuticals policy Drug development Regulatory requirement Clinical trial Investigational New Drug Drug discovery Pharmaceutical sciences Pharmacology Health | Journal of Health Economics[removed]–185 The price of innovation: new estimates of drug development costs Joseph A. DiMasi a,∗ , Ronald W. Hansen b , Henry G. Grabowski c aAdd to Reading ListSource URL: moglen.law.columbia.eduDownload Document from Source WebsiteFile Size: 282,71 KBShare Document on Facebook |
PDF DocumentDocID: 1xvUb - View Document | |
PDF DocumentDocID: 1xc8R - View Document | |
Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MMEDocID: 1vqsj - View Document | |
Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, LatviaDocID: 1vlJU - View Document | |
Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -PharmacologyDocID: 1vk1K - View Document |